Search Results - "Lie, M. R. K. L."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment by Lie, M. R. K. L., Peppelenbosch, M. P., West, R. L., Zelinkova, Z., Woude, C. J.

    Published in Alimentary pharmacology & therapeutics (01-11-2014)
    “…Summary Background Adalimumab is an effective therapy for Crohn's disease patients. However, there is limited knowledge on the pharmacokinetic properties of…”
    Get full text
    Journal Article
  2. 2

    Practical Guideline for Fatigue Management in Inflammatory Bowel Disease by Kreijne, J. E., Lie, M. R. K. L., Vogelaar, L., van der Woude, C. J.

    Published in Journal of Crohn's and colitis (01-01-2016)
    “…During active inflammatory bowel disease (IBD) fatigue is a common symptom, which seems related to active gut inflammation. However, even in remission many…”
    Get full text
    Journal Article
  3. 3

    P287 Patient sex does not affect endoscopic outcomes of biologicals in patients with inflammatory bowel disease, but is possibly associated with adverse events: A systematic review by Lie, M R K L, Paulides, E, van der Woude, C J

    Published in Journal of Crohn's and colitis (15-01-2020)
    “…Abstract Background There are several known factors influencing the efficacy and tolerability of biological therapies. Whether patient sex affects this is…”
    Get full text
    Journal Article